Humacyte HUMA
NASDAQ HUMA
$0.41 +0.01 (+1.28%)
At close: Oct 21, 2026 · 4:00 PM EDT

Humacyte (HUMA) Notes Payables (2020 - 2021)

Updated

Humacyte (HUMA) reported Notes Payables of $7,172 for Q1 2021, down 92.5% from the prior quarter.

Analysis

Humacyte (HUMA) Notes Payables (2020 - 2021) Analysis & Trends

At the end of FY2020, Humacyte posted Notes Payables of $95,136.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Humacyte 97.33 Mn -101.11 Mn -825,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 7,172.00
Dec 31, 2020 95,136.00
Sep 30, 2020 89,076.00
API Access

Humacyte Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=HUMA&period=max&api_key=YOUR_API_KEY